Chemomab Therapeutics (CMMB) Property, Plant & Equipment (Net) Growth (3y) (2020 - 2025)
Chemomab Therapeutics (CMMB) Property, Plant & Equipment (Net) Growth (3y) (2020 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
PP&E (Net) Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
860,679.92 Bn |
860,679.89 Bn |
- |
- |
| 2 |
Belite Bio |
55,284.00 Bn |
55,284.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
16,206.94 Bn |
16,206.93 Bn |
- |
-14.40% |
| 4 |
Legend Biotech |
3,318.00 Bn |
3,317.71 Bn |
242.10 Mn |
3.41% |
| 5 |
Akari Therapeutics |
1,543.84 Bn |
1,543.84 Bn |
- |
- |
| 6 |
Evaxion A |
1,449.11 Bn |
1,449.09 Bn |
- |
- |
| 7 |
Psyence Biomedical |
216.99 Bn |
216.98 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
115.22 Bn |
107.97 Bn |
2.59 Bn |
13.10% |
| 9 |
Abivax |
90.58 Bn |
90.58 Bn |
- |
- |
| 10 |
Chemomab Therapeutics |
831.67 Mn |
821.31 Mn |
- |
-21.73% |
| Date | Value |
|---|
| Dec 31, 2025 |
-21.73% |
| Sep 30, 2025 |
-20.91% |
| Jun 30, 2025 |
-15.13% |
| Mar 31, 2025 |
-12.85% |
| Dec 31, 2024 |
-11.20% |
| Sep 30, 2024 |
3.84% |
| Jun 30, 2024 |
4.34% |
| Mar 31, 2024 |
24.99% |
| Dec 31, 2023 |
25.85% |
| Sep 30, 2023 |
177.06% |
| Jun 30, 2023 |
165.80% |
| Mar 31, 2023 |
42.75% |
| Dec 31, 2022 |
32.44% |
| Sep 30, 2022 |
0.89% |
| Jun 30, 2022 |
-3.33% |
| Dec 31, 2021 |
-2.49% |
| Dec 31, 2020 |
-11.46% |
